Skip to main content

Press releases | September 3, 2021

Fried Frank counseled BofA Securities as financial advisor to Hillrom in its US$12.4 billion acquisition by Baxter International (Baxter). Hillrom is a global medical technology producer. 

Baxter is a medical products company. The addition of Hillrom's product portfolio will enable Baxter to provide better access to care in the hospital, home, and alternate site settings. The transaction is expected to close by early 2022.

The Fried Frank team was led by corporate partner Roy Tannenbaum and included corporate partner Philip Richter and corporate associates Alexander G. Feldsott and Ryan T. Fung.


This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.